Form 8-K - Current report:
SEC Accession No. 0001641172-25-014689
Filing Date
2025-06-11
Accepted
2025-06-11 16:01:29
Documents
12
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 57853
  Complete submission text file 0001641172-25-014689.txt   222958

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE indp-20250610.xsd EX-101.SCH 3020
3 XBRL LABEL FILE indp-20250610_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE indp-20250610_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3579
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 251039870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)